Projects

The Institut Pasteur (Paris) and the Institut Pasteur International Network have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus. This virus is responsible for the new infectious respiratory disease called Covid-19 (for CoronaVIrus Disease). This mobilization brings together hundreds of people from the Institut Pasteur in Paris and several teams from the Network in many countries. A coronavirus task force was set up by the Institut Pasteur in January to launch and coordinate new Covid-19 research projects. Other projects are carried out in partnership or with the support of third-party organizations.
Task force SARS-CoV-2 - Institut Pasteur
Accelerating the identification & design of SARS-CoV2 antiviral drugs in combination with the “DrugDesign_SARS2” project
inSilico_Drugs_to_Beat_SARS2 project
See more
Defective viral genomes (DVGs), potential antiviral inhibitors of SARS-CoV-2
SARS-DVGs project
See more
Task Force Coronavirus - Institut Pasteur - 2020
Drug Repurposing & Design to inhibit the SARS-CoV2 proteases
CoV2-Anti-protease project
See more
Task force SARS-CoV-2 - Institut Pasteur
Find potent antiviral drugs against SARS-CoV2 by targeting well identified proteins essential to the viral cycle
DrugDesign_SARS2 project
See more
Task force SARS-CoV-2 - Institut Pasteur
Identification and isolation of potent human neutralizing antibodies against SARS-CoV-2
NABCOV project
See more
Task Force Coronavirus - Institut Pasteur 2020
Isolating and characterizing the human antibodies that neutralize SARS-CoV-2
2019-NCOV THERAMAB project
See more
Task force SARS-CoV-2 - Institut Pasteur
Urgent Discovery of Drug Candidates That Target Coronavirus SARS-CoV-2
DrugCandidates-SARS-CoV-2 project
See more
Back to top